None
EN
Comment on Will Cracking Down on Drug Ads Help Patients? by Steve McCrea
['Mia Editors', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright']
Comments for Mad In America
After FDA changed the regulations so that only a few major risks need be mentioned, as long as a viewer was referred to a site with full information, broadcast ads became ubiquitous.
However, pharmaceutical ads already contain some risk information; it’s doubtful that additional warnings, especially when happy images are being displayed while risks are being described, will dim the enthusiasm of consumers.
And it’s unreasonable to expect accurate health information from advertising.
The entire purpose of ads is to increase demand for a product and — cost aside — pharmaceutical ads are brilliant examples of creativity in advertising.
So, curbing DTC drug advertising is unlikely to achieve the goal of curbing excessive prescriptions or rising drug spending.